Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Mots-clés originaux en anglais » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Keywords

Liste des classifications (clusters par fréquence et par distance de cosinus):

Pour accéder à une entrée :

Les termes de plus forte occurence

1301Parkinson's disease
147Parkinson’s disease
110Parkinson disease
102levodopa
100dementia
96deep brain stimulation
77depression
74dopamine
73Alzheimer's disease
64subthalamic nucleus
63parkinsonism
59genetics
58epidemiology
48multiple system atrophy
45Parkinson
44LRRK2
41substantia nigra
39neuroprotection
39neurodegeneration
37dyskinesia
36quality of life
35α‐synuclein
35gait
33progressive supranuclear palsy
33basal ganglia
33MPTP
32dopamine agonists
32PET
30cognition
29motor fluctuations
27treatment
26olfaction
26magnetic resonance imaging
26Wolff‐Parkinson‐White syndrome
25Lewy bodies
24essential tremor
24SPECT
23dementia with Lewy bodies
23Parkinsonism
22positron emission tomography
22hallucinations
22dyskinesias
22dopamine agonist
22MRI
22Lewy body
21prevalence
21mortality
21mitochondria
21diagnosis
21atrial fibrillation
21Dopamine
21Alzheimer disease
20tremor
20risk factors
20psychosis
19sleep
19parkin
19mutation
19PINK1
19PD
19Huntington's disease
18striatum
18motor complications
18freezing of gait
18dystonia
18dopamine transporter
18cognitive impairment
18alpha‐synuclein
18UPDRS
18Levodopa
17rating scales
17oxidative stress
17movement disorders
17entacapone
17apomorphine
16elderly
16assessment
16L‐dopa
15progression
15mild cognitive impairment
15UPDRS = Unified Parkinson's Disease Rating Scale
14smoking
14rehabilitation
14rasagiline
14globus pallidus
14Alzheimer’s disease
13tyrosine hydroxylase
13microglia
13fatigue
13falls
13catheter ablation
13association
13anxiety
13Lewy body disease
12transcranial magnetic stimulation
12neuropathology
12disability
12differential diagnosis
12clinical trial
12Substantia nigra
12REM sleep behavior disorder
12PD, Parkinson’s disease
11systematic review
11supraventricular tachycardia
11selegiline
11physical therapy
11health‐related quality of life
11exercise
11bradykinesia
11Neurodegeneration
116‐hydroxydopamine
10voxel‐based morphometry
10visual hallucinations
10ubiquitin
10therapy
10restless legs syndrome
10pramipexole
10postural instability
10neurodegenerative diseases
10dysphagia
10clinimetrics
10clinical trials
10cerebrospinal fluid
10autonomic nervous system
10arrhythmia
10apathy
10Striatum
10Gaucher disease
10Aging
9wearing‐off
9serotonin
9ropinirole
9review
9proteasome
9prognosis
9pathological gambling
9pallidotomy
9nonmotor symptoms
9meta‐analysis
9inflammation
9incidence
9idiopathic Parkinson's disease
9glucocerebrosidase
9excessive daytime sleepiness
9balance
9aging
9Unified Parkinson's Disease Rating Scale
9Parkin
9Basal ganglia
8validity
8transcranial sonography
8polymorphism
8pathogenesis
8pain
8orthostatic hypotension
8neuropsychology
8impulse control disorders
8human
8homocysteine
8dysarthria
8disease progression
8diffusion‐weighted imaging
8cell death
8bromocriptine
8biomarker
8autonomic dysfunction
8attention
8apoptosis
8accessory pathway
8ablation
8TH
8Parkinson's
8Parkinson's Disease
8Huntington disease
8Dementia
7stroke
7sleep disorders
7preexcitation
7parkinson's disease
7neuropsychiatry
7neurodegenerative disorders
7monoamine oxidase
7impulsivity
7hyposmia
7gambling
7freezing
7fMRI
7diffusion tensor imaging
7daytime sleepiness
7constipation
7cognitive function
7coffee
7apolipoprotein E
7antipsychotics
7amyotrophic lateral sclerosis
7amygdala
7UPDRS, Unified Parkinson’s Disease Rating Scale
7SNCA
7Positron emission tomography
7Parkinson's disease dementia
7PSP
7Oxidative stress
7ECG
7Disorders of the nervous system
7Deep brain stimulation
76‐OHDA
6ventricular tachycardia
6uric acid
6transplantation
6thalamotomy
6synuclein
6survival
6surgery
6smell
6rotenone
6reliability
6rat
6physiotherapy
6norepinephrine
6non‐motor symptoms
6neurotoxicity
6neurodegenerative disease
6mobility
6immunohistochemistry
6family history
6familial Parkinson's disease
6executive functions
6etiology
6electrophysiology
6dopaminergic neurons
6continuous dopaminergic stimulation
6cohort study
6amyloid
6amantadine
6age at onset
6aetiology
6WPW
6Tremor
6Selegiline
6STN, subthalamic nucleus
6Motor fluctuations
6HVA
6Dyskinesias
6Dementia with Lewy bodies
6DBS
6Bromocriptine
6AV
5working memory
5tauopathies
5sudden death
5substantia nigra pars compacta
5speech
5safety
5rotigotine
5psychiatric symptoms
5postural control
5polysomnography
5plasticity
5placebo
5pharmacotherapy
5pergolide
5pathophysiology
5outcome
5non‐motor
5nonmotor
5neurosurgery
5motor impairment
5motor control
5monotherapy
5mitochondrial DNA
5linkage
5leucine‐rich repeat kinase 2
5kinase
5iron
5hippocampus
5genetic
5gene expression
5executive function
5dysautonomia
5deprenyl
5cluster analysis
5cardiomyopathy
5cancer
5biomarkers
5behavior
5autonomic
5autonomic failure
5atypical parkinsonism
5anticholinergics
5ageing
5Wolff–Parkinson–White syndrome
5SPM = statistical parametric mapping
5SNP
5ROI = region of interest
5Putamen
5Progressive supranuclear palsy
5Pergolide
5Parkinson's disease (PD)
5PDQ‐39
5PARK2
5Multiple system atrophy
5Mitochondria
5MRI, magnetic resonance imaging
5Human
5HPLC
5Gait
5G2019S
5Epidemiology
5Depression
5DBS, deep brain stimulation
5DA
5COMT inhibition
56-OHDA
4vision
4ubiquitin‐proteasome system
4thalamus
4tau
4synucleinopathy
4symptoms
4subthalamic nucleus stimulation
4sleep disturbance
4side‐effects
4sialorrhea
4serotonin transporter
4screening
4risk factor
4repetitive transcranial magnetic stimulation
4reaction time
4quetiapine
4questionnaire
4putamen
4psychometrics
4proteomics
4prospective study
4proprioception
4primates
4prefrontal cortex
4piribedil
4pharmacokinetics
4pharmacoepidemiology
4penetrance
4nursing home
4neuropsychological
4neurological disorders
4neuroinflammation
4neuroimaging
4motor
4motor symptoms
4motor cortex
4morbidity
4monoamine oxidase inhibitors
4microarray
4memory
4manganese
4linkage disequilibrium
4linkage analysis
4levetiracetam
4incidental Lewy body disease
4imaging
4human brain
4homovanillic acid
4hallucination
4genetic testing
4genes
4gene therapy
4gait variability
4gait disorder
4gait analysis
4functional magnetic resonance imaging
4functional imaging
4function
4frontotemporal dementia
4fluctuations
4evidence‐based medicine
4drooling
4disease severity
4corticobasal degeneration
4complex disease
4complex I
4cohort studies
4cognitive
4cognitive functions
4cognitive deficits
4clinical phenotype
4clinical features
4cerebellum
4cell therapy
4caffeine
4brain atrophy
4autosomal recessive parkinsonism
4autopsy
4atrophy
4atrial flutter
4asymmetry
4astrocyte
4arrhythmias
4animal models
4age of onset
4activities of daily living
4UPSIT
4Tyrosine hydroxylase
4Transplantation
4Thalamotomy
4Taiwanese
4SMA = supplementary motor area
4Rehabilitation
4Prevalence
4Pramipexole
4Parkinson's disease/parkinsonism
4Pallidotomy
4PSP = progressive supranuclear palsy
4PRKN
4PARK8
4Neural transplantation
4NMDA
4Magnetic resonance imaging
4MSA
4MMSE = Mini-Mental State Examination
4MIBG scintigraphy
4L‐DOPA
4Lewy body dementia
4Huntington’s disease
4HD
4Genetics
4GPi = globus pallidus internus
4Electromyography
4Dopamine agonist
4DOPAC
4DLB = dementia with Lewy bodies
4DJ‐1
4Cognition
4Cerebrospinal fluid
4Caudate nucleus
4Cabergoline
4CFT
4BA = Brodmann area
4AVNRT
41-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
3α-synuclein
3α-Synuclein
3women
3wearing off
3visual hallucination
3variant
3urodynamics
3tyramine
3transgenic mouse
3test–retest reliability
3synucleinopathies
3synchronization
3swallowing
3suicide
3sudden cardiac death
3subthalamic
3subthalamic stimulation
3stimulation
3stereotaxy
3stem cell
3staging
3sporadic
3speech therapy
3speech disorder
3spectroscopy
3somatosensory evoked potential
3single photon emission computed tomography (SPECT)
3signal transduction
3reward
3reactive oxygen species
3rTMS
3rCBF = regional cerebral blood flow
3punding
3psychometric properties
3psychiatry
3protein aggregation
3promoter
3primate
3population‐based
3population
3polymorphisms
3phosphorylation
3pharmacology
3pediatrics
3pathology
3parkinsonian disorders
3oxidative phosphorylation
3oxidative damage
3outcomes research
3outcome measures
3osteoporosis
3olfactory bulb
3nutrition
3nursing
3nucleus accumbens
3nitric oxide
3nicotine
3neurotrophic factors
3neurophysiology
3neurology
3neuroleptics
3neural transplantation

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/corpus/Parkinson.storage/ParkinsonV1/Data/Main/Exploration/KwdEn.i.hfd| SxmlCut idx/l | grep ...
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024